NCT07032194 Prospective Study on the Use of the Da Vinci SP System in Urological Surgery
| NCT ID | NCT07032194 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione del Piemonte per l'Oncologia |
| Condition | Urologic Surgical Procedure |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-02-19 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-02-19 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective observational study aimed at evaluating the feasibility, safety, and effectiveness of the Da Vinci SP robotic system for urologic procedures at IRCCS Candiolo. The study collects perioperative, oncologic, and functional outcomes, with exploratory comparisons to the multiport Da Vinci Xi system.
Eligibility Criteria
Inclusion Criteria: * Signed informed consent and data privacy consent * Clinical indication for urologic robotic surgery per EAU guidelines or clinical trial eligibility * ECOG Performance Status 0-1 * Life expectancy ≥ 10 years * Availability of preoperative clinical data * Willingness to comply with follow-up visits and data collection * Eligibility for robotic surgery Exclusion Criteria: * Unsuitability for anesthesia * Cognitive or psychiatric disorders affecting consent or compliance
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07032194 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urologic Surgical Procedure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07032194 currently recruiting?
Yes, NCT07032194 is actively recruiting participants. Contact the research team at enrico.checcucci@ircc.it for enrollment information.
Where is the NCT07032194 trial being conducted?
This trial is being conducted at Candiolo, Italy.
Who is sponsoring the NCT07032194 clinical trial?
NCT07032194 is sponsored by Fondazione del Piemonte per l'Oncologia. The trial plans to enroll 250 participants.